Europe — EMA
Olanzapine Clonmel Healthcare
Olanzapine, the active ingredient in Olanzapine Clonmel Healthcare, is an atypical antipsychotic presented as a unknown/unknown for oral use. It treats schizophrenia and bipolar disorder in adults and adolescents.
Request sourcing
What is Olanzapine?
Olanzapine, the active ingredient in Olanzapine Clonmel Healthcare, is an atypical antipsychotic presented as a unknown/unknown for oral use. It treats schizophrenia and bipolar disorder in adults and adolescents. GNH USA supplies Olanzapine Clonmel Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Olanzapine used for?
Olanzapine is an atypical antipsychotic that modulates neurotransmitter activity in several psychiatric disorders.
- Schizophrenia: Improves psychotic symptoms such as delusions and hallucinations. - Bipolar I disorder: Helps control manic episodes and maintenance therapy. - Psychotic depression: Augments antidepressant response when combined with - Acute
What are the side effects of Olanzapine?
There
